Skip to main content

Aytu Biopharma, Inc

AYTU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001385818

No open-market purchases or sales by Aytu Biopharma, Inc insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q3 2026, worth $7.95M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 20, 2026
$28.9M
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026, −2 vs. previous quarter
35
13F valueReported value at the end of Q3 2026
$7.95M
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2026
$57.6M
−13.3% year over year
Net income, FY2026
-$14.3M
No comparable prior period
Free cash flow, FY2026
$3.25M
No comparable prior period
Revenue, Q1 FY2027
$14.8M
+6.9% year over year

Revenue flow, FY2026

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2026: $14.3M (24.8% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
301.7K
Shares sold short
Change
−27.2K
−8.3% vs. previous
Days to cover
11.65
At average daily volume

Superinvestors holding AYTU, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding AYTU at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Aytu Biopharma, Inc insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 10, 2025 (view filing)Jun 91 dayDisbrow JarrettChief Business OfficerPPurchase+16.7K$1.50+$25.0K+130.2%29.5K after
Jun 10, 2025 (view filing)Jun 91 dayDisbrow Joshua R.Chief Executive OfficerPPurchase+66.7K$1.50+$100.0K+77.0%153.3K after
Jun 9, 2025 (view filing)4:31 PM ETJun 63 daysNantahala Capital Management, LLC and 2 others10% OwnerPPurchase+4.00M$1.50+$6.00M–4.82M afterDerivative
Mar 3, 2025 (view filing)Feb 283 daysDisbrow Joshua R.Chief Executive OfficerPPurchase+15.0K$1.30+$19.5K+21.0%86.6K after
Jun 20, 2023 (view filing)Jun 164 daysPyszczymuka GregChief Commerical OfficerPPurchase+12.0K$1.87+$22.4K+120.8%21.9K after
Jun 15, 2023 (view filing)Jun 141 dayDisbrow Joshua R.Chief Executive OfficerPPurchase+14.0K$1.86+$26.0K+24.3%71.6K after
Dec 21, 2022 (view filing)9:17 AM ETDec 192 daysDisbrow Joshua R.Chief Executive OfficerPPurchase+112.4K$0.2229+$25.0K+10.0%1.23M after
Dec 21, 2022 (view filing)9:15 AM ETDec 192 daysPyszczymuka GregChief Commercial OfficerPPurchase+100.0K$0.2448+$24.5K+121.9%182.1K after
Nov 28, 2022 (view filing)4:30 PM ETNov 1810 daysOki Mark KChief Financial OfficerPPurchase+90.0K$0.23+$20.7K+90.0%190.0K afterAmended
Nov 28, 2022 (view filing)4:30 PM ETNov 1810 daysDisbrow Joshua R.Chief Executive OfficerPPurchase+222.0K$0.237+$52.6K+24.7%1.12M afterAmended

Top 10 13F holders, Q3 2026

See all 35 holders

The largest institutional positions in Aytu Biopharma, Inc at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding AYTU in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Nantahala Capital Management, LLC1,086,812$2.33M0.13%00.0%Unchanged
Stonepine Capital Management, LLC964,900$2.06M1.72%+51,979+5.7%Added
AWM Investment Company, Inc.619,574$1.33M0.13%00.0%Unchanged
Vanguard Capital Management LLC261,146$558.9K0.00%00.0%Unchanged
Crown Advisors Management, Inc.200,000$428.0K0.30%00.0%Unchanged
Geode Capital Management, LLC123,670$264.7K0.00%+30,023+32.1%Added
Renaissance Technologies LLC121,623$260.3K0.00%+16,800+16.0%Added
Diadema Partners LP67,186$143.8K0.05%−81,360−54.8%Reduced
Two Sigma Investments, LP65,513$140.2K0.00%−39,813−37.8%Reduced
Dimensional Fund Advisors LP50,046$107.1K0.00%+4,720+10.4%Added

Holders of 5% or more of AYTU

See all 3 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Aytu Biopharma, Inc.

Largest holders of AYTU from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Nantahala Capital Management, LLC13D/A14.40%1.09M shares–May 26, 20234 filingsJun 9, 2025SEC
Stonepine Capital Management, LLC13G/A9.90%906.1K shares–Feb 12, 20216 filingsAug 13, 2025SEC
AWM Investment Company, Inc.13G/A5.80%619.6K shares−1.10 ppfrom 6.90%Aug 14, 20252 filingsFeb 13, 2026SEC